AI
JNJ icon

Arvest Investments’s Johnson & Johnson JNJ Stock Holding History

Arvest Investments’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
7,022
-1,866
-21% -$435K 0.22% 70
2026
Q1 		$2.17M Sell
8,888
-2,491
-22% -$580K 0.3% 60
2025
Q4 		$2.35M Sell
11,379
-387
-3% -$76.5K 0.33% 59
2025
Q3 		$2.18M Sell
11,766
-158
-1% -$27.1K 0.31% 63
2025
Q2 		$1.82M Sell
11,924
-2,900
-20% -$446K 0.27% 70
2025
Q1 		$2.46M Sell
14,824
-483
-3% -$75.6K 0.39% 54
2024
Q4 		$2.21M Sell
15,307
-1,114
-7% -$173K 0.35% 57
2024
Q3 		$2.66M Sell
16,421
-4,470
-21% -$712K 0.4% 53
2024
Q2 		$3.05M Sell
20,891
-328
-2% -$48.8K 0.49% 44
2024
Q1 		$3.36M Sell
21,219
-5,650
-21% -$899K 0.53% 39
2023
Q4 		$4.21M Buy
+26,869
New +$4.12M 0.68% 37

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Arvest Investments's JNJ Position: Q2 2026 in Review

Arvest Investments reduced its Johnson & Johnson (JNJ) stake by 21% in Q2 2026, selling an estimated $435K and leaving 7,022 shares worth $1.78M. The position accounts for 0.22% of the portfolio, ranked #70.

Arvest Investments first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.21M in Q4 2023. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Arvest Investments held 7,022 shares of Johnson & Johnson worth $1.78M as of Q2 2026.
  • Arvest Investments sold 1,866 Johnson & Johnson shares in Q2 2026, an estimated $435K.
  • Johnson & Johnson made up 0.22% of Arvest Investments's portfolio in Q2 2026, its #70 holding.
  • Arvest Investments first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Arvest Investments's Johnson & Johnson position peaked at $4.21M in Q4 2023.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Arvest Investments's 13F filing for Q2 2026, filed 17 Jul 2026.